GLAXF
Price
$18.16
Change
-$0.00 (-0.00%)
Updated
Aug 7 closing price
Capitalization
103.73B
HAWPF
Price
$10.62
Change
+$1.22 (+12.98%)
Updated
Aug 5 closing price
Capitalization
1.62B
Interact to see
Advertisement

GLAXF vs HAWPF

Header iconGLAXF vs HAWPF Comparison
Open Charts GLAXF vs HAWPFBanner chart's image
GSK
Price$18.16
Change-$0.00 (-0.00%)
Volume$277
Capitalization103.73B
Haw Par
Price$10.62
Change+$1.22 (+12.98%)
Volume$100
Capitalization1.62B
GLAXF vs HAWPF Comparison Chart in %
Loading...
GLAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HAWPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GLAXF vs. HAWPF commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GLAXF is a Buy and HAWPF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (GLAXF: $18.16 vs. HAWPF: $10.62)
Brand notoriety: GLAXF and HAWPF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GLAXF: 6% vs. HAWPF: 30%
Market capitalization -- GLAXF: $103.73B vs. HAWPF: $1.62B
GLAXF [@Pharmaceuticals: Major] is valued at $103.73B. HAWPF’s [@Pharmaceuticals: Major] market capitalization is $1.62B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GLAXF’s FA Score shows that 1 FA rating(s) are green whileHAWPF’s FA Score has 1 green FA rating(s).

  • GLAXF’s FA Score: 1 green, 4 red.
  • HAWPF’s FA Score: 1 green, 4 red.
According to our system of comparison, GLAXF is a better buy in the long-term than HAWPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GLAXF’s TA Score shows that 3 TA indicator(s) are bullish while HAWPF’s TA Score has 3 bullish TA indicator(s).

  • GLAXF’s TA Score: 3 bullish, 6 bearish.
  • HAWPF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, HAWPF is a better buy in the short-term than GLAXF.

Price Growth

GLAXF (@Pharmaceuticals: Major) experienced а -4.52% price change this week, while HAWPF (@Pharmaceuticals: Major) price change was +12.98% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.43%. For the same industry, the average monthly price growth was +6.77%, and the average quarterly price growth was +13.43%.

Industries' Descriptions

@Pharmaceuticals: Major (-0.43% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLAXF($104B) has a higher market cap than HAWPF($1.62B). GLAXF has higher P/E ratio than HAWPF: GLAXF (17.36) vs HAWPF (13.91). HAWPF YTD gains are higher at: 32.750 vs. GLAXF (7.935). GLAXF has higher annual earnings (EBITDA): 10B vs. HAWPF (149M). GLAXF has more cash in the bank: 14B vs. HAWPF (3.09B). HAWPF has less debt than GLAXF: HAWPF (12.9M) vs GLAXF (33.3B). GLAXF has higher revenues than HAWPF: GLAXF (36.5B) vs HAWPF (171M).
GLAXFHAWPFGLAXF / HAWPF
Capitalization104B1.62B6,416%
EBITDA10B149M6,711%
Gain YTD7.93532.75024%
P/E Ratio17.3613.91125%
Revenue36.5B171M21,345%
Total Cash14B3.09B452%
Total Debt33.3B12.9M258,140%
FUNDAMENTALS RATINGS
GLAXF vs HAWPF: Fundamental Ratings
GLAXF
HAWPF
OUTLOOK RATING
1..100
1044
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
88
Overvalued
PROFIT vs RISK RATING
1..100
10043
SMR RATING
1..100
4073
PRICE GROWTH RATING
1..100
6044
P/E GROWTH RATING
1..100
3428
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GLAXF's Valuation (8) in the null industry is significantly better than the same rating for HAWPF (88). This means that GLAXF’s stock grew significantly faster than HAWPF’s over the last 12 months.

HAWPF's Profit vs Risk Rating (43) in the null industry is somewhat better than the same rating for GLAXF (100). This means that HAWPF’s stock grew somewhat faster than GLAXF’s over the last 12 months.

GLAXF's SMR Rating (40) in the null industry is somewhat better than the same rating for HAWPF (73). This means that GLAXF’s stock grew somewhat faster than HAWPF’s over the last 12 months.

HAWPF's Price Growth Rating (44) in the null industry is in the same range as GLAXF (60). This means that HAWPF’s stock grew similarly to GLAXF’s over the last 12 months.

HAWPF's P/E Growth Rating (28) in the null industry is in the same range as GLAXF (34). This means that HAWPF’s stock grew similarly to GLAXF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GLAXFHAWPF
RSI
ODDS (%)
Bullish Trend 1 day ago
62%
Bearish Trend 1 day ago
35%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
21%
Momentum
ODDS (%)
Bearish Trend 1 day ago
49%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
54%
Bullish Trend 1 day ago
33%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
56%
Bullish Trend 1 day ago
28%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
28%
Advances
ODDS (%)
Bullish Trend 12 days ago
64%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
51%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
67%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
45%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GLAXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HAWPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LTH27.370.38
+1.41%
Life Time Group Holdings
MITK9.150.03
+0.33%
Mitek Systems
AEE102.320.31
+0.30%
Ameren Corp
HURC19.03-0.20
-1.04%
Hurco Companies
INTS0.25-0.02
-7.63%
Intensity Therapeutics

GLAXF and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLAXF has been loosely correlated with GSK. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GLAXF jumps, then GSK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLAXF
1D Price
Change %
GLAXF100%
N/A
GSK - GLAXF
37%
Loosely correlated
+2.26%
OPHLY - GLAXF
9%
Poorly correlated
-0.45%
HAWPF - GLAXF
8%
Poorly correlated
N/A
ORINY - GLAXF
6%
Poorly correlated
-12.25%
GIKLY - GLAXF
5%
Poorly correlated
N/A
More

HAWPF and

Correlation & Price change

A.I.dvisor tells us that HAWPF and CSWYF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HAWPF and CSWYF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAWPF
1D Price
Change %
HAWPF100%
N/A
CSWYF - HAWPF
27%
Poorly correlated
N/A
RHHVF - HAWPF
21%
Poorly correlated
+0.37%
BMY - HAWPF
20%
Poorly correlated
+1.20%
GLAXF - HAWPF
8%
Poorly correlated
N/A
OPHLY - HAWPF
8%
Poorly correlated
-0.45%
More